Biogenerics

The whole biogeneric/biosimmilar issue has become completely mad and incomprehensible to even those of above average intelligence. In the end, the branded companies want to keep out generic competitors and the generic players want in. The situation is very complex but in a sense no different to the situation regarding generic products of the past where big pharma tried to convince consumers as well as the regulatory authorities that generic products were inferior. Eventually it became clear that generics were clinically equivalent to the branded products but nonetheless, we are still inundated with citizens petitions and all kinds of legal maneuvers designed to thwart competition and delay approvals of generic drugs. This is perfectly legal and obviously the branded companies have every right to use all means at their disposal to protect their economic assets, but nonetheless, it is clearly a very expensive delaying tactic that costs the consumer and society millions. That said, since many pharmaceuticals are essentially consumer type products, I suppose this is an indulgence for which society doesn't mind paying.

Well my last blog disapeared a day afer I Created it

Well Well